Communiqués TELA Bio, Inc.

Actions

TELA

US8723811084

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 16/07/2024			Varia. 5j.	Varia. 1 janv.
4,76 ^USD	+1,28 %		+15,25 %	-28,10 %

04/06	TELA Bio, Inc. nomme Jeffrey Blizard à son conseil d'administration	CI
20/05	TELA Bio, Inc. nomme Greg Firestone au poste de directeur commercial	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

TELA Bio Appoints Jeffrey Blizard to its Board of Directors	04/06	GL
TELA Bio Appoints Greg Firestone as Chief Commercial Officer	20/05	GL
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	10/05	GL
TELA Bio Reports First Quarter 2024 Financial Results	09/05	GL
Morgans rates ARX as Add	01/05	AQ
TELA Bio to Announce First Quarter 2024 Financial Results	25/04	GL
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR, Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures	16/04	AQ
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures	15/04	GL
TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy	08/04	GL
TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results	21/03	GL
TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery	21/03	GL
MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing	20/03	AQ
TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX	20/03	GL
TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results	29/02	GL
TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results	29/02	AQ
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	23/02	GL
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	19/01	GL
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	15/12	GL
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	15/12	AQ
TELA Bio to Take Part in Connecting the Dots	05/12	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués TELA Bio, Inc.

Actions

TELA

US8723811084

Communiqués

Filtres